PAINT - Apoptosis (Archived)

From GO Wiki
Jump to navigation Jump to search

This page captures PANTHER families with annotations to 'execution phase of apoptosis' GO:0097194. The definition is "A stage of the apoptotic process that starts with the controlled breakdown of the cell through the action of effector caspases or other effector molecules (e.g. cathepsins, calpains etc.). Key steps of the execution phase are rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. The execution phase ends when the cell has died." Thus, all signaling events *upstream from* the effector caspases (those include CASP3, CASP6, CASP7) should *not* be annotated to this term. Initiator caspases (e.g., CASP2, CASP8, CASP9, and CASP10) should also not be annotated to this term. See and for general background.

Apoptosis Project Report

In November 2013 we decided to assign families to annotators with the goal of setting clear deliverables. Having a common topic was expected to facilitate discussions among annotators. We chose apoptosis because the ontology and the annotations were recently revisited.

  1. Verification of the tree topology and composition
  2. Overview of literature on protein family function
  3. Ensuring sufficient annotation coverage
  4. Annotating ancestral genes

However until now most of the communication has been on the 'propagation' aspect of the annotation (step 4). As we go along, we realize that reviewing the primary annotations in light of a broad knowledge about a family is an essential step. This doesn't always result in changes in annotations, but if nothing else, it helps curators ensure that the primary annotations are correct and capture all the important aspect of a family's biological role. In some cases that review may uncover deeper problems with annotation of certain proteins, or with the interpretation of certain GO terms. We need to make sure that this 'integrative' aspect of the PAINT process gets well communicated both to members of the GOC and outside.

  • Annotation review/quality control*

The most critical issue underlying incorrect annotations has to do with the understanding of the semantics of a GO annotation, ie, what does it mean when we associate a gene/protein with a GO term?

Specifically, those are common misinterpretations we encounter:

  • Difficulty to distinguish between annotation to a process versus annotation to the regulation of that process. Because of the non-transitive nature of the 'regulation' relation, this has important implications for downstream data analysis.
  • Difficulty to distinguish between experimental READOUT or ENDPOINT that is measured, and a real role in the process itself. This results in large number of over-annotations when proteins have an upstream/indirect role.

Out of 15 families, only 2 were correctly annotated to 'execution phase 'of apoptosis'. We need to evaluate the extent of this issue in the GO as a whole.

  • The Protein2GO Dispute Mechanism* was very helpful as a way to discuss questionable annotations. We suggest that this get adopted as one of the tools for the PAINT workflow. Hopefully that will also help keep record of the disputed annotations and make stats with respect to which GO terms are more problematic.
  • Ontology updates*

The Apoptosis PAINT curation project also resulted in several ontology updates; creation and obsoletion of terms; and addition of comments to help annotators use terms correctly.

Suggested action points from the apoptosis work:

  1. Change the emphasis of PAINT from 'phylogenetic annotation propagation' to 'Phylogenetic-based annotation integration'*
  2. Communicate those issues at an annotation call.
  3. Identify similar situations where annotators have a hard time distinguishing between readouts and processes and provide guidelines.
  4. Continue using PAINT as a mechanism for reviewing annotations.

This table is no longer being updated. Please contact the PAINT team for access to the shared online document.

'Please sign up for a family, and comment after you submit them to the SVN repository.'

Family PTHR ID Curator Execution phase of apoptosis annotation justified?
cell death activator cide PTHR12306 Moni -- committed No - negative regulation of execution phase of apoptosis
DNA fragmentation subunit Beta PTHR13067 Moni -- committed Yes - apoptotic DNA fragmentation
map-kinase activating death domain protein (madd)/denn/aex-3(c.elegans) PTHR13008 Moni -- in progress
caspase PTHR10454 Paul Yes
calpain PTHR10183 Rama
mitogen-activated kinase kinase kinase PTHR24361 Huaiyu -- committed No. PAKs are target of caspases, but not necessarily in the execution phase of apoptosis.
sorting nexin PTHR10555 Rama
40s ribosomal protein s3a PTHR11830 Pascale - committed No - positive regulation of extrinsic apoptotic signaling pathway. Family also contains CYLD, a ubiquitin dehydrolase, that I annotated in Protein2GO on Dec 19 - still need to annotate "GO:0061578 Lys63-specific deubiquitinase activity" in PAINT
akt-related serine/threonine-protein kinase PTHR24352 DHL
bcl-2 related PTHR11256 Huaiyu -- committed No. Bcl2 related proteins are involved in the cytochrome c release from mitochondria, which leads to the activation of caspase cascade, so they are not in the execution phase of apoptosis.
bcl2/adenovirus e1b 19-kda protein-interacting protein PTHR12112 Moni -- not committed. Yes. BNIPL-2 interferes with GAP activity of Cdc42GAP toward Cdc42. Cdc42 recruits PAK1 and activates JNK1 to phosphorylate, which consequently inactivates the anti-apoptotic Bcl-2 protein, allowing p53-dependent apoptosis.
disulfide oxidoreductase PTHR22912 Paul No - caspase-independent apoptosis
ephrin PTHR11304 Li -- committed It's a "not" annotation to 'execution phase of apoptosis' GO:0097194. PMID:11870224 shows EphA3-expressing cell show morphological changes such as membrane blebbing. In contrast to apoptotic blebbs, which are static and often detach from the cell surface, ephrin-A5 triggers highly dynamic, spherical membrane protrusions that do not lead to cell fragmentation. "not" apoptosis process instead?
ets PTHR11849 Rama
f-box and wd40 domain protein PTHR22844 Rama
family not named PTHR18834 Li -- committed No - SRA overexpression enhanced apoptosis in mammary epithelia
family not named PTHR24025 Karen - not well enough annotated to do PAINT No - Dsg2 is a target of caspase 3, not playing a role in the execution phase itself
group ii pyridoxal-5-phosphate decarboxylase PTHR11999 Rama
microtubule-associated protein PTHR13843 DHL
nadh dehydrogenase-related PTHR22915 Rama
protein arginine n-methyltransferase PTHR11006 Pascale -- committed No (the paper shows that "Transfection of PRMT2 into 293 cells increased their susceptibility to TNF-induced cell death"; is this really sufficient evidence for an annotation?)
protein disulfide isomerase PTHR18929 Paul No - regulation of apoptosis
rbm25 protein PTHR18806 Pascale - committed No - regulation of alternative mRNA splicing, via spliceosome. Note that it regulates BCL-x spilcing.
telomeric repeat binding protein PTHR21717 Li -- committed No, regulation term is better choice or just apoptosis process
tumor protein d52 PTHR19307 Karen - not well enough annotated to do PAINT No - not execution phase, regulation of apoptotic signalling
type i interferon PTHR11691 Pascale - commited No, should be regulation of apoptosis (human IFNB1)
u3 small nucleolar rna-associated protein 11 PTHR12838 Karen - committed No - experiment supports "positive regulation of apoptotic process" at best; however, fairly old non-specific experiment and this family is now known to be the Utp11 component of the small subunit processome, and that disruption of ribosomal biogenesis and nucleolar structure leads to activation of cell cycle arrest and/or apoptosis; not clear that role of Utp11 in apoptosis is specific
ubiquilin PTHR10677 DHL

To do next: Families annotated to children of 'execution phase of apoptosis'

Family PTHR ID Curator Execution phase of aopoptosis annotation justified?
glucagon PTHR11418 Pascale -- commited No - negative regulation of apoptosis
30s/40s ribosomal protein s3 PTHR11760 Pascale -- commited No - regulation of apoptosis
rho-type gtpase activating protein PTHR12659 Moni -- in progress
family not named (BNIP3) PTHR15186 Pascale -- committed No - In fact, apoptosis is wrong here. BNIP3 mediate caspase-independent programmed cell death
cop9 signalosome complex subunit 7/dendritic cell protein ga17 PTHR15350 Pascale -- committed No - Mutant has defect in apoptosis; regulation would be better
myosin light chain kinase-related PTHR22964
paraneoplastic antigen PTHR23095 Pascale - committed No - regulation
translation factor PTHR23115 Pascale - Will not do yet; translation factor, big family, all factors should be done at same time No
family not named PTHR24271 Li -- committed yes
family not named PTHR24272 Moni -- in progress
family not named (PTGIS) PTHR24295 - now PTHR24306 Pascale -- committed No, regulation of apoptosis
family not named PTHR24377 Pascale -- committed No, regulation of apoptosis // Zinc finger - huge family 2000 proteins
family not named PTHR32047 Li -- committed no, PMID:11466612 shows activities of caspase-3 like proteases enhanced twofold in Bcl10 transfected 293T cells, further experiments show Bcl10 may involved in apoptosis signaling by alter its binding partners...